BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cai JS, Chen JH. The mechanism of enterohepatic circulation in the formation of gallstone disease. J Membr Biol 2014;247:1067-82. [PMID: 25107305 DOI: 10.1007/s00232-014-9715-3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 3.9] [Reference Citation Analysis]
Number Citing Articles
1 Ghaffarzadegan T, Zanzer YC, Östman E, Hållenius F, Essén S, Sandahl M, Nyman M. Postprandial Responses of Serum Bile Acids in Healthy Humans after Ingestion of Turmeric before Medium/High-Fat Breakfasts. Mol Nutr Food Res 2019;63:e1900672. [PMID: 31411373 DOI: 10.1002/mnfr.201900672] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Ruszkowski J, Witkowski JM. Lactulose: Patient- and dose-dependent prebiotic properties in humans. Anaerobe 2019;59:100-6. [PMID: 31176002 DOI: 10.1016/j.anaerobe.2019.06.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 5.7] [Reference Citation Analysis]
3 Ji Y, Yin Y, Sun L, Zhang W. The Molecular and Mechanistic Insights Based on Gut-Liver Axis: Nutritional Target for Non-Alcoholic Fatty Liver Disease (NAFLD) Improvement. Int J Mol Sci 2020;21:E3066. [PMID: 32357561 DOI: 10.3390/ijms21093066] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
4 Malik MY, Jaiswal S, Sharma A, Shukla M, Lal J. Role of enterohepatic recirculation in drug disposition: cooperation and complications. Drug Metab Rev 2016;48:281-327. [PMID: 26987379 DOI: 10.3109/03602532.2016.1157600] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
5 Zhao SF, Wang AM, Yu XJ, Wang LL, Xu XN, Shi GJ. Association between gallstone and cardio-cerebrovascular disease: Systematic review and meta-analysis. Exp Ther Med 2019;17:3092-100. [PMID: 30936980 DOI: 10.3892/etm.2019.7291] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 van Niekerk G, Davis T, de Villiers W, Engelbrecht AM. The role of bile acids in nutritional support. Crit Care 2018;22:231. [PMID: 30268137 DOI: 10.1186/s13054-018-2160-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
7 Yip C, Okada NC, Howerton A, Amei A, Abel-Santos E. Pharmacokinetics of CamSA, a potential prophylactic compound against Clostridioides difficile infections. Biochem Pharmacol 2021;183:114314. [PMID: 33152344 DOI: 10.1016/j.bcp.2020.114314] [Reference Citation Analysis]
8 Chen J, Sali A, Vitetta L. The gallbladder and vermiform appendix influence the assemblage of intestinal microorganisms. Future Microbiology 2020;15:541-55. [DOI: 10.2217/fmb-2019-0325] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Meadows V, Kennedy L, Kundu D, Alpini G, Francis H. Bile Acid Receptor Therapeutics Effects on Chronic Liver Diseases. Front Med (Lausanne) 2020;7:15. [PMID: 32064266 DOI: 10.3389/fmed.2020.00015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
10 de Haan LR, Verheij J, van Golen RF, Horneffer-van der Sluis V, Lewis MR, Beuers UHW, van Gulik TM, Olde Damink SWM, Schaap FG, Heger M, Olthof PB. Unaltered Liver Regeneration in Post-Cholestatic Rats Treated with the FXR Agonist Obeticholic Acid. Biomolecules 2021;11:260. [PMID: 33578971 DOI: 10.3390/biom11020260] [Reference Citation Analysis]
11 Brønden A, Knop FK. Gluco-Metabolic Effects of Pharmacotherapy-Induced Modulation of Bile Acid Physiology. J Clin Endocrinol Metab 2020;105:dgz025. [PMID: 31630179 DOI: 10.1210/clinem/dgz025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
12 Kundu S, Kumar S, Bajaj A. Cross-talk between bile acids and gastrointestinal tract for progression and development of cancer and its therapeutic implications. IUBMB Life 2015;67:514-23. [PMID: 26177921 DOI: 10.1002/iub.1399] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
13 Grigor'eva IN, Romanova TI. Gallstone Disease and Microbiome. Microorganisms 2020;8:E835. [PMID: 32498344 DOI: 10.3390/microorganisms8060835] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
14 Wang G, Han T, Wang S, Chen M, Sun Y, Fu Z. Peroxisome Proliferator-Activated Receptor-γ Prevents Cholesterol Gallstone Formation in C57bl Mice by Regulating Bile Acid Synthesis and Enterohepatic Circulation. Biomed Res Int 2018;2018:7475626. [PMID: 30105244 DOI: 10.1155/2018/7475626] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
15 Sasikumar S, Chameettachal S, Kingshott P, Cromer B, Pati F. 3D hepatic mimics - the need for a multicentric approach. Biomed Mater 2020;15:052002. [PMID: 32460259 DOI: 10.1088/1748-605X/ab971c] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Liu F, Wang X, Li D, Cui Y, Li X. Apple polyphenols extract alleviated dextran sulfate sodium-induced ulcerative colitis in C57BL/6 male mice by restoring bile acid metabolism disorder and gut microbiota dysbiosis. Phytother Res 2021;35:1468-85. [PMID: 33215776 DOI: 10.1002/ptr.6910] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
17 Tao F, Xing X, Wu J, Jiang R. Enteral nutrition modulation with n-3 PUFAs directs microbiome and lipid metabolism in mice. PLoS One 2021;16:e0248482. [PMID: 33764993 DOI: 10.1371/journal.pone.0248482] [Reference Citation Analysis]
18 Chen CH, Lin CL, Kao CH. Risk of aortic dissection or aneurysm in patients with gallstone disease: a retrospective cohort study in Taiwan. BMJ Open 2021;11:e049316. [PMID: 34446491 DOI: 10.1136/bmjopen-2021-049316] [Reference Citation Analysis]
19 Fani B, Bertani L, Paglianiti I, Fantechi L, De Bortoli N, Costa F, Volterrani D, Marchi S, Bellini M. Pros and Cons of the SeHCAT Test in Bile Acid Diarrhea: A More Appropriate Use of an Old Nuclear Medicine Technique. Gastroenterol Res Pract. 2018;2018:2097359. [PMID: 30598661 DOI: 10.1155/2018/2097359] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
20 Ghaffarzadegan T, Essén S, Verbrugghe P, Marungruang N, Hållenius FF, Nyman M, Sandahl M. Determination of free and conjugated bile acids in serum of Apoe(-/-) mice fed different lingonberry fractions by UHPLC-MS. Sci Rep 2019;9:3800. [PMID: 30846721 DOI: 10.1038/s41598-019-40272-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
21 Kube I, Zwanziger D. Thyroid Dysfunction and Cholesterol Gallstone Disease. Exp Clin Endocrinol Diabetes 2020;128:455-61. [PMID: 31797343 DOI: 10.1055/a-1033-7273] [Reference Citation Analysis]
22 Nuño-Lámbarri N, Barbero-Becerra VJ, Uribe M, Chávez-Tapia NC. Elevated cholesterol levels have a poor prognosis in a cholestasis scenario. J Biochem Mol Toxicol 2017;31:1-6. [PMID: 27517733 DOI: 10.1002/jbt.21831] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
23 Kriaa A, Bourgin M, Potiron A, Mkaouar H, Jablaoui A, Gérard P, Maguin E, Rhimi M. Microbial impact on cholesterol and bile acid metabolism: current status and future prospects. J Lipid Res 2019;60:323-32. [PMID: 30487175 DOI: 10.1194/jlr.R088989] [Cited by in Crossref: 57] [Cited by in F6Publishing: 34] [Article Influence: 14.3] [Reference Citation Analysis]
24 Zheng X, Smith FB, Aly NA, Cai J, Smith RD, Patterson AD, Baker ES. Evaluating the structural complexity of isomeric bile acids with ion mobility spectrometry. Anal Bioanal Chem 2019;411:4673-82. [PMID: 31098744 DOI: 10.1007/s00216-019-01869-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
25 Kubica K, Balbus J. A computer study of the risk of cholesterol gallstone associated with obesity and normal weight. Sci Rep 2021;11:8868. [PMID: 33893348 DOI: 10.1038/s41598-021-88249-w] [Reference Citation Analysis]
26 Islam MS, Sharif A, Kwan N, Tam KC. Bile Acid Sequestrants for Hypercholesterolemia Treatment Using Sustainable Biopolymers: Recent Advances and Future Perspectives. Mol Pharm 2022. [PMID: 35333534 DOI: 10.1021/acs.molpharmaceut.2c00007] [Reference Citation Analysis]
27 Kaewmalee J, Ontawong A, Duangjai A, Tansakul C, Rukachaisirikul V, Muanprasat C, Srimaroeng C. High-Efficacy α,β-Dehydromonacolin S Improves Hepatic Steatosis and Suppresses Gluconeogenesis Pathway in High-Fat Diet-Induced Obese Rats. Pharmaceuticals (Basel) 2021;14:375. [PMID: 33920678 DOI: 10.3390/ph14040375] [Reference Citation Analysis]
28 Żulpo M, Balbus J, Kuropka P, Kubica K. A model of gallbladder motility. Computers in Biology and Medicine 2018;93:139-48. [DOI: 10.1016/j.compbiomed.2017.12.018] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
29 Lin CW, Lin SX, Kankala RK, Busa P, Deng JP, Lue SI, Liu CL, Weng CF, Lee CH. Surface-functionalized layered double hydroxide nanocontainers as bile acid sequestrants for lowering hyperlipidemia. Int J Pharm 2020;590:119921. [PMID: 33027632 DOI: 10.1016/j.ijpharm.2020.119921] [Reference Citation Analysis]
30 Kuyooro SE, Akintunde JK, Okekearu FC, Maduagwu EN. Toxicokinetics and Biliary Excretion of N-Nitrosodiethylamine in Rat Supplemented with Low and High Dietary Proteins. J Diet Suppl 2019;16:506-20. [PMID: 30513225 DOI: 10.1080/19390211.2018.1471561] [Reference Citation Analysis]